Skip to content
Rare Disease Tracker
Most Favored Nation Tracker
Rare Disease Tracker
Most Favored Nation Tracker
Methodology
All entries for: Zomagen Biosciences Ltd, a wholly owned subsidiary of Ventyx Biosciences, Ltd.
February 13, 2026
Zomagen Biosciences Ltd, a wholly owned subsidiary of Ventyx Biosciences, Ltd.
Orphan Drug Designation
treatment of pericarditis
Disease Area:
Rare Disease
Source
Source
Scroll to Top
